These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 4694690

  • 1. Comparative study of the absorption, plasma levels, and urinary excretion of the "new" and the "old" Lanoxin.
    Falch D, Teien A, Bjerkelund CJ.
    Br Med J; 1973 Mar 24; 1(5855):695-7. PubMed ID: 4694690
    [Abstract] [Full Text] [Related]

  • 2. Biological availability of digoxin from Lanoxin produced in the United Kingdom.
    Johnson BF, Fowle AS, Lader S, Fox J, Munro-Faure AD.
    Br Med J; 1973 Nov 10; 4(5888):323-6. PubMed ID: 4758424
    [Abstract] [Full Text] [Related]

  • 3. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
    O'Grady J, Johnson BF, Bye C, French J.
    Eur J Clin Pharmacol; 1978 Dec 18; 14(5):357-60. PubMed ID: 729628
    [Abstract] [Full Text] [Related]

  • 4. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
    Johnson BF, Smith G, French J.
    Br J Clin Pharmacol; 1977 Apr 18; 4(2):209-11. PubMed ID: 861135
    [Abstract] [Full Text] [Related]

  • 5. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF, Lindenbaum J, Budnitz E, Marwaha R.
    Clin Pharmacol Ther; 1986 Mar 18; 39(3):306-12. PubMed ID: 3948469
    [Abstract] [Full Text] [Related]

  • 6. Maximal bioavailability of digoxin from tablets and oral solution in steady state.
    Manninen V, Reissell P, Ojala K.
    Acta Med Scand; 1976 Mar 18; 199(6):487-9. PubMed ID: 937075
    [Abstract] [Full Text] [Related]

  • 7. Comparison of steady-state serum concentrations of digoxin in tablets (Lanoxin) and capsules (Lanoxicaps) in the elderly.
    Pouwels MJ, Hooymans PM, van der Aa GC, Gribnau FW.
    DICP; 1991 Oct 18; 25(10):1043-6. PubMed ID: 1803786
    [Abstract] [Full Text] [Related]

  • 8. [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests].
    Bodem G, Ochs H, Hahn E, Dengler HJ.
    Schweiz Med Wochenschr; 1977 May 14; 107(19):658-66. PubMed ID: 867012
    [Abstract] [Full Text] [Related]

  • 9. Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment.
    Okada RD, Hager WD, Graves PE, Mayersohn M, Perrier DG, Marcus FI.
    Circulation; 1978 Dec 14; 58(6):1196-203. PubMed ID: 709776
    [Abstract] [Full Text] [Related]

  • 10. Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
    Bjornsson TD, Huang AT, Roth P, Jacob DS, Christenson R.
    Clin Pharmacol Ther; 1986 Jan 14; 39(1):25-8. PubMed ID: 3943266
    [Abstract] [Full Text] [Related]

  • 11. Bioavailability studies with Digoxin-Sandoz and Lanoxin.
    Beveridge T, Kalberer F, Nüesch E, Schmidt R.
    Eur J Clin Pharmacol; 1975 Jun 13; 8(5):371-6. PubMed ID: 1243983
    [Abstract] [Full Text] [Related]

  • 12. A completely absorbed oral preparation of digoxin.
    Johnson BF, Bye C, Jones G, Sabey GA.
    Clin Pharmacol Ther; 1976 Jun 13; 19(6):746-51. PubMed ID: 1269214
    [Abstract] [Full Text] [Related]

  • 13. Serum-digoxin concentrations with a new digoxin derivative, beta-methyl-digoxin.
    Härtel G, Manninen V, Melin J, Apajalahti A.
    Ann Clin Res; 1973 Apr 13; 5(2):87-90. PubMed ID: 4748756
    [No Abstract] [Full Text] [Related]

  • 14. Transition from Lanoxin capsules to Lanoxin tablets in the debilitated elderly.
    Drinka PJ, Nickel DA, Schomisch GW, Depka CH, Deterville RJ.
    DICP; 1990 Apr 13; 24(4):381-2. PubMed ID: 2327116
    [Abstract] [Full Text] [Related]

  • 15. The influence of digoxin particle size on absorption of digoxin and the effect of propantheline and metoclopramide.
    Johnson BF, O'Grady J, Bye C.
    Br J Clin Pharmacol; 1978 May 13; 5(5):465-7. PubMed ID: 656287
    [Abstract] [Full Text] [Related]

  • 16. Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration.
    Johnson BF, Bye C.
    Br Heart J; 1975 Feb 13; 37(2):203-8. PubMed ID: 1091283
    [Abstract] [Full Text] [Related]

  • 17. Absorption of digoxin from a new microencapsulated formulation.
    Bergdahl B, Bogentoft C, Jonsson UE, Magnusson JO.
    Eur J Clin Pharmacol; 1980 Jun 13; 17(6):443-7. PubMed ID: 7398735
    [Abstract] [Full Text] [Related]

  • 18. Effect of a standard breakfast on digoxin absorption in normal subjects.
    Johnson BF, O'Grady J, Sabey GA, Bye C.
    Clin Pharmacol Ther; 1978 Mar 13; 23(3):315-9. PubMed ID: 627138
    [Abstract] [Full Text] [Related]

  • 19. Recent changes in biological availability of digoxin. Effect of an alteration in 'Lanoxin' tablets.
    Shaw TR, Howard MR, Hamer J.
    Br Heart J; 1974 Jan 13; 36(1):85-9. PubMed ID: 4818143
    [No Abstract] [Full Text] [Related]

  • 20. Bioavailability of drugs: the digoxin dilemma.
    Greenblatt DJ, Smith TW, Koch-Weser J.
    Clin Pharmacokinet; 1976 Jan 13; 1(1):36-51. PubMed ID: 797491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.